Illumina Is Maintained at Buy by Guggenheim
Illumina Analyst Ratings
Piper Sandler Remains a Buy on Illumina (ILMN)
Stifel Nicolaus Reaffirms Their Buy Rating on Illumina (ILMN)
Citi Maintains Illumina(ILMN.US) With Hold Rating, Maintains Target Price $85
Barclays Maintains Illumina(ILMN.US) With Sell Rating, Cuts Target Price to $77
Research Alert: Ilmn: No Major Surpises In Q1 Results, Yet Guidance Points To Weakened Outlook
Bernstein Maintains Illumina(ILMN.US) With Hold Rating
CCORF Maintains Illumina(ILMN.US) With Hold Rating, Cuts Target Price to $92
Illumina Is Maintained at Hold by Canaccord Genuity
Illumina Analyst Ratings
Leerink Partners Maintains Illumina(ILMN.US) With Buy Rating, Announces Target Price $115
Bernstein Maintains Illumina(ILMN.US) With Hold Rating, Cuts Target Price to $90
Piper Sandler Maintains Illumina(ILMN.US) With Buy Rating, Maintains Target Price $190
BofA Securities Cuts Price Target on Illumina to $75 From $90, Keeps Underperform Rating
Bernstein Maintains Illumina(ILMN.US) With Hold Rating, Maintains Target Price $130
Illumina Is Maintained at Underweight by Barclays
TD Cowen Maintains Illumina(ILMN.US) With Hold Rating, Cuts Target Price to $86
RBC Capital Maintains Illumina(ILMN.US) With Buy Rating, Cuts Target Price to $112
Illumina Is Maintained at Outperform by RBC Capital